Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis. Swiss HIV Cohort Study

MLA

H, Furrer, et al. “Stopping Primary Prophylaxis in HIV-1-Infected Patients at High Risk of Toxoplasma Encephalitis. Swiss HIV Cohort Study.” Lancet (London, England), vol. 355, no. 9222, July 2000. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........eca0ebab741fa88451a71cee5977e7ae&authtype=sso&custid=ns315887.

APA

H, F., M, O., E, B., A, T., & M, E. (2000). Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis. Swiss HIV Cohort Study. Lancet (London, England), 355(9222).

Chicago

H, Furrer, Opravil M, Bernasconi E, Telenti A, and Egger M. 2000. “Stopping Primary Prophylaxis in HIV-1-Infected Patients at High Risk of Toxoplasma Encephalitis. Swiss HIV Cohort Study.” Lancet (London, England) 355 (9222). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........eca0ebab741fa88451a71cee5977e7ae&authtype=sso&custid=ns315887.